FL-CTS-ENGINES
CTS Engines, the global leader for mature engine maintenance within the Aerospace & Defense industry, announced today that it had inducted the first PW2000 engine into its engine overhaul facility in Ft. Lauderdale, FL. Along with the CF6-80C2, CF6-80A, and CF6-50C2, the PW2000 represents the fourth engine model type serviced by CTS.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180814005021/en/
“The profile of the PW2000 engine—which will continue to operate on B757s in cargo configuration and on C-17 Globemaster military transport aircraft for years to come—is an ideal fit for the CTS product line,” said Vesa Paukkeri, CTS’s President and Chief Operating Officer. “CTS is the go-to independent jet engine MRO for sunset engines operating in cargo and military transport configurations. We look forward to servicing this engine through the remainder of its time on wing over the next 30+ years.”
Based in Ft. Lauderdale, CTS Engines is the worldwide leader in mature engine maintenance, performing engine overhauls on the CF6-50, CF6-80A, CF6-80C, and PW2000 engine models at its 105,000 square foot Ft. Lauderdale MRO facilities. At its 155,000 lbf test stand in Jupiter, Fla., the company also performs mature engine return to service tests, as well as OEM developmental tests for new engine platforms. For more information, please visit www.ctsengines.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180814005021/en/
Contact:
CTS Engines
Alejandra Meza, 954-889-0640
ameza@ctsengines.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KINAXIS-INC.26.4.2024 18:04:28 CEST | Press release
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions
VERTEX-PHARMA26.4.2024 17:44:28 CEST | Press release
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
SUZANO-S.A.26.4.2024 17:23:27 CEST | Press release
Suzano 2023 annual report on Form 20-F
MA-TAKEDA-PHARMACEUTICAL26.4.2024 14:31:34 CEST | Press release
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
WOLTERS-KLUWER26.4.2024 14:01:34 CEST | Press release
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom